Wainwright and coworkers [122] setup an orthotopic model based on intracranial injection of glioblastoma cell lines and treatment with blocking antibodies against PD-L1 or other immune checkpoints, such as CTLA-4 and IDO. Here, IDO1 is linked to glioblastoma.